HCW Biologics Inc. (HCWB) stock
HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)
Close on Nov 18, 2026Market cap $1.40MP/E –Yield –
HCW Biologics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
HCW Biologics's price to book ratio was 0.1× on Nov 11, 2026, against 4.5× a year earlier. Over the last 4 years it ranged from 0.1× to 4.7×, with a median of 1.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.1× | −2.4 |
| 2024 | Jul 31, 2024 | 2.5× | +0.7 |
| 2023 | Dec 29, 2023 | 1.8× | +0.2 |
| 2022 | Dec 30, 2022 | 1.6× | +1.1 |
| 2021 | Dec 31, 2021 | 0.5× | – |
See a number that looks wrong?